![7-chloro-9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile](https://static.cymitquimica.com/cas-image/343070-7-chloro-9-oxo-9h-indeno-12-b-pyrazine-23-dicarbonitrile.png)
CAS: 924296-39-9 - 7-chloro-9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile
Fórmula:C13H3ClN4O
InChI:InChI=1/C13H3ClN4O/c14-6-1-2-7-8(3-6)13(19)12-11(7)17-9(4-15)10(5-16)18-12/h1-3H
- Sinónimos:
- 9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile, 7-chloro-9-oxo-
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 7-Chloro-9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile REF: IN-DA0034E9CAS: 924296-39-9 | 98% | A consultar | Mar 21 Ene 25 |
 | HBX 41108 REF: TM-T21527CAS: 924296-39-9 | 95.63% | 51,00 €~872,00 € | Lun 27 Ene 25 |
 | HBX 41108 REF: 3D-FC145339CAS: 924296-39-9 | Min. 95% | 370,00 €~1.065,00 € | Lun 03 Mar 25 |
![7-Chloro-9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile](https://static.cymitquimica.com/products/IN/thumb/DA0034E9.jpg)
7-Chloro-9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile
CAS:924296-39-9
Fórmula:
C13H3ClN4O
Pureza:
98%
Forma y color:
Solid
Peso molecular:
266.6421
Ref: IN-DA0034E9
| 5mg | 274,00 € | ||
| 10mg | 576,00 € | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
HBX 41108
CAS:924296-39-9
HBX 41108: non-competitive, reversible USP7 inhibitor; IC50: 424nM; blocks USP7-p53 deubiquitination; IC50: 0.8μM.
Fórmula:
C13H3ClN4O
Pureza:
95.63%
Forma y color:
Solid
Peso molecular:
266.64
Ref: TM-T21527
| 1mg | 51,00 € | ||
| 2mg | 73,00 € | ||
| 5mg | 109,00 € | ||
| 10mg | 176,00 € | ||
| 25mg | 415,00 € | ||
| 50mg | 612,00 € | ||
| 100mg | 872,00 € |
Entrega estimada en Estados Unidos, el Lunes 27 de Enero de 2025
HBX 41108
CAS:924296-39-9
Inhibitor of ubiquitin-specific protease USP7
Fórmula:
C13H3ClN4O
Pureza:
Min. 95%
Peso molecular:
266.64 g/mol
Ref: 3D-FC145339
| 5mg | 370,00 € | ||
| 10mg | 559,00 € | ||
| 25mg | 1.065,00 € |
Entrega estimada en Estados Unidos, el Lunes 3 de Marzo de 2025
